Nonadherence to inhaled corticosteroids is associated with negative mepolizumab response
Mohammed Ghazi Almutairi, John Marriott, Zahraa Jalal, Louise Wood, Samantha Caddick, Babita Rajkumari, Susan Renwick, Siobhan Wilkinson, Caroline Gallagher, Hollie Morgan, Adel H. Mansur · 2026
Read Nonadherence to inhaled corticosteroids is associated with negative mepolizumab response by Mohammed Ghazi Almutairi, John Marriott, Zahraa Jalal, Louise Wood, Samantha Caddick, Babita Rajkumari, Susan Renwick, Siobhan Wilkinson, Caroline Gallagher, Hollie Morgan, Adel H. Mansur (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13678659.txt.
Description
Mohammed Ghazi Almutairi and colleagues published an asthma study in 2026 on patients taking a biologic drug. The drug, mepolizumab, treats severe asthma driven by eosinophils. Patients also need daily inhaled steroids to control the disease. Skipping those inhalers is common and may blunt the biologic's benefit.
The team reviewed records of about one hundred ninety adults. Most patients responded well to the biologic. Responders suffered far fewer asthma attacks than nonresponders. Roughly a third of patients had not collected their inhalers regularly. That pattern appeared before and during biologic treatment. Nonadherence was more common among those who failed to respond. The authors urge checking inhaler use before judging a biologic failed.
Catalog record
| CREATOR | Mohammed Ghazi Almutairi, John Marriott, Zahraa Jalal, Louise Wood, Samantha Caddick, Babita Rajkumari, Susan Renwick, Siobhan Wilkinson, Caroline Gallagher, Hollie Morgan, Adel H. Mansur |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 36 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |